A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera, Nature, vol.100, issue.7037, pp.1144-1152, 2005. ,
DOI : 10.1182/blood-2002-09-2839
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders, The Lancet, vol.365, issue.9464, pp.1054-61, 2005. ,
DOI : 10.1016/S0140-6736(05)74230-6
in Myeloproliferative Disorders, New England Journal of Medicine, vol.352, issue.17, pp.1779-90, 2005. ,
DOI : 10.1056/NEJMoa051113
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis, Cancer Cell, vol.7, issue.4, pp.387-97, 2005. ,
DOI : 10.1016/j.ccr.2005.03.023
The JAK2-V617F mutation is frequently present at diagnosis in patients with essential thrombocythemia and polycythemia vera, Blood, vol.108, issue.6, pp.1865-1872, 2006. ,
DOI : 10.1182/blood-2006-01-013540
Detection of JAK2 V617F as a first intention diagnostic test for erythrocytosis, Leukemia, vol.106, issue.2, pp.350-353, 2006. ,
DOI : 10.1038/sj.leu.2404069
Polycythemia Vera: Scientific Advances and Current Practice, Seminars in Hematology, vol.42, issue.4, pp.206-226, 2005. ,
DOI : 10.1053/j.seminhematol.2005.08.003
Mutation screening for JAK2V617F: When to order the test and how to interpret the results, Leukemia Research, vol.30, issue.6, pp.739-783, 2006. ,
DOI : 10.1016/j.leukres.2006.01.004
Diagnostic value of serum erythropoietin level in patients with absolute erythrocytosis, Haematologica, vol.89, pp.1194-1202, 2004. ,
The incidence of the JAK2 V617F mutation in patients with idiopathic erythrocytosis, Haematologica, vol.91, pp.413-417, 2006. ,